Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06271655 · ClinicalTrials.gov registry record · NA
Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)
A NA study of Viral Infection and Acute Respiratory Infection, sponsored by Christopher Payette.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06271655 is a NA study of Viral Infection and Acute Respiratory Infection that is active but no longer recruiting, run by Christopher Payette. The registered enrollment target is 200 participants, roughly in line with the 211-participant average among 11 other Viral Infection trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06271655, a NA study of Viral Infection and Acute Respiratory Infection, is active but no longer recruiting, sponsored by Christopher Payette.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The study titled " The Effect of Definitive Identification of Viral Etiology in Emergency Department Patients with Acute Respiratory Infection on Antibiotic Utilization (RADIATE)" aims to investigate the effectiveness of a rapid diagnostic approach in reducing unnecessary antibiotic use in the emergency department (ED) for patients presenting with acute respiratory illness (ARI) due to a virus. Using a prospective design, eligible participants are individuals who visit the ED with complaints related to acute respiratory illness. The study will employ a single-arm consecutive enrollment approach. The intervention involves the implementation of a rapid point-of-care multiplex polymerase chain reaction (PCR) test to promptly identify the viral cause of the infection. By utilizing a rapid diagnostic tool to identify viral etiology, the study aims to provide healthcare professionals in the ED with more accurate information to guide treatment decisions. Ultimately, the goal is to decrease the unnecessary use of antibiotics for ARI's due to a virus, which has several negative outcomes including promotion of antibiotic resistance, exacerbating ED length of stay and encouraging unnecessary additional diagnostic tests.
Conditions Studied
Interventions
- DEVICE SPOTFIRE R Panel
Study Locations (1)
District of Columbia
- George Washington University Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-03-12 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06271655
The ClinicalTrials.gov registry entry for NCT06271655 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 211-participant average among 11 other Viral Infection trials with a reported enrollment target. The listed sponsor is Christopher Payette, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Viral Infection appearing as the primary indexed condition, and to 1 intervention - of which SPOTFIRE R Panel is the first listed.
NCT06271655 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06271655 about?
NCT06271655 is a clinical study titled "Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)". The study titled " The Effect of Definitive Identification of Viral Etiology in Emergency Department Patients with Acute Respiratory Infection on Antibiotic Utilization (RADIATE)" aims to investigate the effectiveness of a rapid diagnostic approach in reducing unnecessary antibiotic use in the emerg...
What is the current status of trial NCT06271655?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-03-12. Estimated completion is 2026-12-31.
What conditions does trial NCT06271655 study?
This clinical trial studies the following conditions: Viral Infection, Acute Respiratory Infection, Upper Respiratory Tract Infections.
What interventions are being tested in trial NCT06271655?
The interventions under investigation include: SPOTFIRE R Panel (DEVICE).
Who is sponsoring clinical trial NCT06271655?
This trial is sponsored by Christopher Payette, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06271655 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Viral Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
School Inner City Air Study
RECRUITING · NA
-
Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
RECRUITING · NA
-
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
RECRUITING · Phase 1
-
Third Party Viral Specific T-cells (VSTs)
RECRUITING · Phase 2
-
Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
RECRUITING · Phase 1
-
Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
RECRUITING · Phase 2
Explore more on PlainTrial
Viral Infection
All registered trials for this condition
Acute Respiratory Infection
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.